Koers Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
37,4 CNY | +0,51% | -12,68% | -21,84% |
Omzet 2023 | 91,29 mln. 12,62 mln. 11,81 mln. | Omzet 2024 * | 490 mln. 67,73 mln. 63,41 mln. | Marktkapitalisatie | 15,55 mld. 2,15 mld. 2,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -1,12 mld. -155 mln. -145 mln. | Nettowinst (verlies) 2024 * | -649 mln. -89,7 mln. -83,99 mln. | EV/omzet 2023 | 214 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 31,7 x |
K/w-verhouding 2023 |
-17,4
x | K/w-verhouding 2024 * |
-24
x | Werknemers | 424 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 18,48% |
1 dag | +0,51% | ||
1 week | -12,68% | ||
Lopende maand | -16,87% | ||
1 maand | -16,18% | ||
3 maanden | -8,80% | ||
6 maanden | +6,49% | ||
Lopend jaar | -21,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 37,4 | +0,51% | 1 843 790 |
16-04-24 | 37,21 | -6,97% | 2 385 552 |
15-04-24 | 40 | -3,85% | 1 655 487 |
12-04-24 | 41,6 | -1,56% | 724 781 |
11-04-24 | 42,26 | -1,33% | 594 754 |
slotkoers Shanghai S.E., 17 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,84% | 2,15 mld. | |
-3,39% | 102 mld. | |
+2,61% | 96,84 mld. | |
-1,92% | 21,48 mld. | |
-18,14% | 20,82 mld. | |
-6,87% | 18,6 mld. | |
-40,70% | 16,81 mld. | |
-26,89% | 13,78 mld. | |
+1,12% | 13,4 mld. | |
+22,25% | 11,06 mld. |